The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
Ideaya Biosciences Inc (NASDAQ: IDYA) closed the day trading at $14.77 down -9.83% from the previous closing price of $16.38. In other words, the price has decreased by -$9.83 from its previous closing price. On the day, 2.68 million shares were traded. IDYA stock price reached its highest trading level at $16.3797 during the session, while it also had its lowest trading level at $14.4.
Ratios:
For a better understanding of IDYA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.97 and its Current Ratio is at 14.97. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on November 18, 2024, initiated with a Overweight rating and assigned the stock a target price of $51.
On November 05, 2024, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $27.
On October 24, 2024, UBS started tracking the stock assigning a Buy rating and target price of $50.UBS initiated its Buy rating on October 24, 2024, with a $50 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 26 ’24 when Jason Throne bought 75,000 shares for $40.22 per share.
WHITE MICHAEL ANTHONY sold 28,500 shares of IDYA for $1,032,884 on May 29 ’24. The Chief Scientific Officer now owns 0 shares after completing the transaction at $36.24 per share. On May 15 ’24, another insider, Hata Yujiro S, who serves as the President and CEO of the company, sold 83,856 shares for $42.90 each. As a result, the insider received 3,597,756 and left with 677,887 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IDYA now has a Market Capitalization of 1292927488 and an Enterprise Value of 635779264. For the stock, the TTM Price-to-Sale (P/S) ratio is 184.70 while its Price-to-Book (P/B) ratio in mrq is 1.21. Its current Enterprise Value per Revenue stands at 90.826 whereas that against EBITDA is -1.959.
Stock Price History:
The Beta on a monthly basis for IDYA is 0.51, which has changed by -0.64958483 over the last 52 weeks, in comparison to a change of 0.08089435 over the same period for the S&P500. Over the past 52 weeks, IDYA has reached a high of $44.42, while it has fallen to a 52-week low of $15.94. The 50-Day Moving Average of the stock is -28.17%, while the 200-Day Moving Average is calculated to be -50.22%.
Shares Statistics:
Over the past 3-months, IDYA traded about 909.71K shares per day on average, while over the past 10 days, IDYA traded about 1196580 shares per day. A total of 86.50M shares are outstanding, with a floating share count of 80.84M. Insiders hold about 7.65% of the company’s shares, while institutions hold 100.98% stake in the company. Shares short for IDYA as of 1741910400 were 9884508 with a Short Ratio of 10.87, compared to 1739491200 on 8898446. Therefore, it implies a Short% of Shares Outstanding of 9884508 and a Short% of Float of 12.57.
